TASMAR UPDATE 04 May 1999 Besides the three cases of tolcapone (Tasmar)-associated fatal liver failures last year among the more than 60,000 users, that prompted the requirement for periodic blood testing, I've found four reports of deaths from other or unknown causes among Tasmar users, with only slight hints of possible liver damage. As of February 1999, I have seen no case where monitoring has not provided effective warning of potential liver failure. Cheers, Joe -- J. R. Bruman (818) 789-3694 3527 Cody Road Sherman Oaks, CA 91403-5013